Cambridge Enterprise, the University’s innovation arm, has published its annual report, highlighting success in supporting new ventures based on Cambridge research.
Speaking about the report and recent activity, Dr Jim Glasheen, Chief Executive, Cambridge Enterprise, said: “Our annual review shows that we are putting our efforts to help founders and translational ideas where it matters most. Collaboration and connection remain central to our approach.
From the opening of our London office through to collaborations on activities such as the Columbia pitch day in New York, we are bringing together Cambridge innovations with leading investors and partners globally. With sustained investment and improved connectivity, we can unlock future economic and societal benefits for the UK.”
Cambridge Enterprise Technology Fund
One such good news story is that of AI firm Trismik, which raised £2.2M in pre-seed funding just 10 months after receiving early-stage support from the Cambridge Enterprise Technology Fund, demonstrating the impact of targeted early-stage funding in attracting further investment.
Launched in 2023, the Technology Fund has invested over £4M in 40 projects to date.
Four Cambridge innovations awarded UKRI Proof-of-Concept funding
UKRI’s new Proof-of-Concept funding provides critical early-stage support to projects, helping researchers and innovators bridge the gap before attracting private investment.
With support from Cambridge Enterprise, all four Cambridge submissions to the inaugural £9M fund – including two Technology Investment Fund projects – were awarded the maximum of £250,000 each. Cambridge secured more funded projects than any other institution, and was the only one to achieve a 100% success rate at the maximum award level.
More details available in the Cambridge Enterprise Annual Review
The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.
